Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | SLC2A1 | P11166 | 1/20 | 1.00 |
| ▸ | GBA1 | P04062 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anisomycin SCHEMBL18059879 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 | |
| Anisomycin SCHEMBL8331774 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 | |
| Anisomycin SCHEMBL2270183 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 | |
| Anisomycin SCHEMBL2270193 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 | |
| Anisomycin SCHEMBL15033472 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 | |
| Anisomycin SCHEMBL2270187 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 | |
| Anisomycin SCHEMBL898674 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 | |
| Anisomycin SCHEMBL1003579 | 0.99 | SMN1; SMN2 (0.97) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 | |
| Anisomycin SCHEMBL6888777 | 0.94 | SMN1; SMN2 (0.89) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 | |
| SCHEMBL18106096 | 0.88 | CYP2D6 (0.78) | SMN1; SMN2CYP2D6ALDH1A1LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5014 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| WO-2026086871-A1 | ANTI-AGEING COMPOUNDS, USES THEREFOR, METHOD FOR IDENTIFYING, AND COMPOSITIONS CONTAINING | Centre for Translational Stem Cell Biology Limited (CN) | 2026-04-30 | — | — | WO | claimed |
| US-12612362-B2 | Anisomycin derivative and use of anisomycin and derivative thereof as GLP-1R agonist | SHANXI MEDICAL UNIVERSITY (CN) | 2026-04-28 | — | — | US | claimed |
| US-20260090969-A1 | COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS | Nuchido Limited (GB) | 2026-04-02 | — | — | US | claimed |
| EP-4712983-A1 | AGENTS TO GENERATE REPAIR OLIGODENDROCYTES AND THEIR USE FOR AXONAL REGROWTH | Johannes Gutenberg-Universität Mainz (DE) | 2026-03-25 | — | — | EP | claimed |
| US-20260029412-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER BY INHIBITING MITOCHONDRIAL STRESS-INDUCED PROTEIN CARBOXYL-TERMINAL ALANINE AND THREONINE TAILING (MSICAT-TAILING) | UNIV SOUTHERN METHODIST (US) | 2026-01-29 | — | — | US | claimed |
| US-20250367182-A1 | METHOD FOR INDUCING IN-SITU REGENERATION OF MAMMAL AND USE THEREOF | INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2025-12-04 | — | — | US | claimed |
| US-20250367183-A1 | SUBSTANCE FOR PROMOTING REGENERATION AND REPAIR OF ORGANS OF MAMMALS AND USE THEREOF | INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2025-12-04 | — | — | US | claimed |
| WO-2025215156-A1 | BIOMARKER OF MK2 ACTIVITY | UNIVERSITETET I TROMSØ - NORGES ARKTISKE UNIVERSITET (NO) | 2025-10-16 | — | — | WO | claimed |
| EP-4596699-A1 | CELL LINE FOR PRODUCING FAF1 EXOSOMES IN HIGH YIELD, AND PREPARATION METHOD THEREFOR | Kainos Medicine, Inc. (KR) | 2025-08-06 | — | — | EP | claimed |
| WO-1999001150-A1 | NOVEL COMPOSITION FOR TREATING, PREVENTING AND/OR DELAYING ISCHEMIC CELL DEATH | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1999-01-14 | — | — | WO | claimed |
| US-5830699-A | STE20 OXIDANT STRESS RESPONSE KINASE, NUCLEOTIDE SEQUENCE, INDUCES CELL CYCLE ARREST | THE GENERAL HOSPITAL CORPORATION (US) | 1998-11-03 | — | — | US | claimed |
| EP-0854722-A1 | PROTEINS INVOLVED IN TARGETING OF PEPTIDYL TRANSFER CENTER, AND CORRESPONDING THERAPEUTIC AGENTS AND METHODS | University of Medicine and Dentistry of New Jersey (US) | 1998-07-29 | — | — | EP | claimed |
| WO-1997012617-A9 | PROTEINS INVOLVED IN TARGETING OF PEPTIDYL TRANSFER CENTER, AND CORRESPONDING THERAPEUTIC AGENTS AND METHODS | — | 1997-09-18 | — | — | WO | claimed |
| WO-1997012617-A1 | PROTEINS INVOLVED IN TARGETING OF PEPTIDYL TRANSFER CENTER, AND CORRESPONDING THERAPEUTIC AGENTS AND METHODS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1997-04-10 | — | — | WO | claimed |
| US-5463078-A | Anisomycin derivatives and anticancer agents, antifungal agents and antiprotozoan agents containing the same | AJINOMOTO CO., INC. (JP) | 1995-10-31 | — | — | US | claimed |
| EP-0612728-A2 | Anisomycin derivatives and anticancer agents, antifungal agents and antiprotozoan agents containing them | Ajinomoto Co., Inc. (JP) | 1994-08-31 | — | — | EP | claimed |
| EP-0243015-B1 | SELECTIVE MEDIA FOR GROWTH OF NEISSERIA | Becton, Dickinson and Company (US) | 1992-11-11 | — | — | EP | claimed |
| US-4814276-A | VANCOMYCIN AND LINCOMYCIN | BECTON, DICKINSON AND COMPANY (US) | 1989-03-21 | — | — | US | claimed |
| EP-0243015-A1 | Selective media for growth of Neisseria | Becton, Dickinson and Company (US) | 1987-10-28 | — | — | EP | claimed |